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Abstract We report a case of a 64 year old woman with a
calcified ring at the level of the sinotubular junction. Echo-
cardiography and Computed Tomography showed a
supravalvular aortic stenosis, without known associated le-
sions, except for the existence of an aberrant right subclavi-
an artery. These combination of abnormalities makes it an
unique case. Differential diagnosis of sinutubular calcifica-
tion is added. From the literature a short review of
supravalvular aortic stenosis is presented with indications
for surgical intervention. Lifelong and regular follow up is
necessary.
Introduction
The best available evidence suggests that overall prev-
alence of congenital heart defect (CHD) in the adult
population is about 3000 per million [1]. The popula-
tion of adults with a congenital heart defect is increas-
ing, due to improved survival after cardiac surgery [1,
2]. Supravalvular aortic stenosis (SVAS) is the least
common form of left ventricular outflow tract (LVOT)
obstruction. In Kitchiner’s series the incidence of
LVOT obstruction was 6.1/10,000 live births. In his
series of 313 patients with LVOT obstruction, SVAS
occurred in 7.7% of the cases [3]. In 51 children,
catheterised for congenital aortic stenosis, Liu detected
7 cases (13.7%) of SVAS [4]. SVAS involves a focal
or diffuse narrowing of the ascending aorta, starting at
the sinotubular (ST) junction. It can be a feature of the
Williams-Beuren syndrome (WBS) [5], an autosomal
dominant multisystem disorder involving besides car-
diovascular abnormalities, also mental retardation, char-
acteristic facial appearance (‘elfin face’) and occasional
idiopathic hypercalcaemia. SVAS can also occur in an
autosomal inherited form without the features of the
WBS or in a rare sporadic form [6]. In all three types,
there is a mutation of the elastin gene on chromosome
7q11.23 [5, 6]. SVAS is also reported to occur in
association with homozygous (44%) [7–9] or heterozy-
gous (4%) familial hypercholesterolaemia (FH) [9].
Case
A woman, 64 years of age, was sent to our outpatient
clinic for evaluation of a cardiac murmur. She had no
cardiac complaints and no family history of cardiac
abnormalities. The medical history revealed only
hypercholesterolaemia and hypertension. For the latter
she was on perindopril 4 mg daily. She had a normal
facial appearance and normal intellect. Her blood
pressure, measured at the right and left arm, was
180/90 and 160/90 mmHg respectively. Her weight
was 78 kg. A grade 2/6 early- and mid-systolic mur-
mur was heard at the 2nd intercostal space on the
right side and at the 4th intercostal space on the left
side of the chest. No other abnormalities were found
on physical examination. The laboratory investigation
showed an elevated total cholesterol and low-density
lipoprotein cholesterol level in the plasma of 7.0 and
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4.4 mmol/l, respectively. High-density lipoprotein cho-
lesterol and triglycerides levels were normal. The
electrocardiogram was completely normal, without
signs of left ventricular (LV) hypertrophy. Echocardi-
ography showed a short circular stenosis at the level
of the ST junction, with a small pressure gradient.
The maximal flow velocity (V-max) at the level of
the SVAS was 1.8 m/s (Fig. 1). Besides some mild
mitral and tricuspid incompetence, no intracardiac
abnormalities were seen. The aortic valve (AV), al-
though not optimally visualised on echocardiography,
was proven tricuspid and normal at computed tomog-
raphy (CT). Also a calcified ring could be imaged at
the level of the ST junction with a minimum diameter of
1.7 cm, followed by a mild poststenotic dilatation of the tubular
ascending aorta of 3.9 cm. There were no calcifications else-
where in the thoracic aorta (Figs. 2 and 3a). Associated lesions
as accompanying supravalvular stenosis of the pulmonary
Fig. 1 Cardiac echocardiography with apical views demonstrating the SVAS (a, left, arrow). Pulsed-wave Doppler measurement shows a maximal
velocity of 1.8 m/s across the stenosis (b, middle). Colour Doppler visualises the turbulence at the level of the ST junction (c, right)
Fig. 2 CT images in a three-chamber plane. Thick (a, left) and thin (b, right) slice maximum intensity projection (MIP) reconstructions, visualising
the calcified ST ridge
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trunk, aortic coarctation, persisting ductus arteriosus, and pul-
monary stenosis were excluded by contrast-enhanced CT.
However, the patient did have an aberrant origin of the right
subclavian artery (arteria lusoria) (Fig. 3b).
Discussion
SVAS can occur as a localised fibrous diaphragm just distal
to the coronary ostia, as an external hourglass deformity
with a corresponding luminal narrowing of the aorta, or as
a diffuse narrowing of the ascending aorta. In this specific
case of SVAS the form of the calcified ring cannot to be
classified in one of the three aforementioned categories.
Such a case has never been published before. The family
history revealed no cardiac disorders and no familial
hypercholesterolaemia (FH). So in our patient there is a
sporadic form of SVAS.
A PubMed search found no earlier publications of a
‘supravalvular’ or ‘supravalvar’ aortic stenosis in the
form of a ‘calcified/calcific ring’, nor an association
with an aberrant right subclavian (artery) or a lusoria
(artery) [10]. A case report was recently published of a
6-year-old girl with familial SVAS and a total occlu-
sion of the brachiocephalic trunk [11]. Calcification of
the ascending aorta has been reported in combination
with a diffuse type SVAS and in patients with homo-
zygous FH. Calcification limited to portions of the ST
ridge has been reported with preference for the right
sinus of Valsalva [12]. These lesions has been de-
scribed as a marker of severe aortic plaque formation
[13]. Other investigators demonstrated that these le-
sions were distinct from aortic atheromatous disease
and were histologically similar to AV calcifications
[14]. Because of the demonstrated mild stenosis with turbu-
lence, our patient must be diagnosed as SVAS. We
hypothesise that our patient originally had a discrete fibrous
stenosis. Mechanical stress has successively led to inflamma-
tion, interstitial cell activation, osteogenic differentiation and
ultimately calcification [15].
Surgery for SVAS is indicated in patients with
symptoms and mean Doppler gradient ≥50 mmHg
[16]. Or <50 mmHg with symptoms and/or LV sys-
tolic dysfunction and/or LV hypertrophy or when cor-
onary bypass operation is indicated [16]. The optimal
surgical procedure for repair is still under debate [6].
In a retrospective study in 75 patients with discrete
stenosis, multisinus aortoplasty resulted in better
haemodynamics and in reductions in both the need
for reoperation and the mortality rate when compared
with patch enlargement of the noncoronary sinus only
[17]. However, these results did not reach statistical
difference [6]. In other studies, the sample size was
even smaller, related to the rarity of the lesion which
makes statistical analysis and generalisation of the
findings a challenge. Hence the ESC Guidelines do
not favour a specific surgical technique [16].
Because there is no significant pressure gradient over the
SVAS in our patient, the treatment could be conservative. In
a recent publication, Greutmann et al. showed that progres-
sion of SVAS in adulthood is rare. Adverse events are
associated with valve disease, particularly the mitral valve
Fig. 3 CT MIP reconstructions. Axial-oblique plane (a, left) showing the calcified ring (arrow, SVAS) and axial plane (b, right) showing the
aberrant right subclavian artery (arrow, LUSORIA) originating from the distal arcus aortae (arrow, ARCUS)
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[18]. The mechanism of the dilatation of the tubular ascend-
ing aorta can be a jet lesion. Also elastin aortopathy is a
possibility. Follow-up remains necessary with specific at-
tention for progression of the obstruction (rare), develop-
ment of aneurysm [19] and coronary artery disease (elevated
prestenotic pressure) [16].
Conclusion
Improvement of contemporary imaging modalities (echocar-
diography, CT and also magnetic resonance imaging) will
increase the discoveries of unknown congenital cardiovas-
cular abnormalities, also later in life. For SVAS, lifelong and
regular follow-up is necessary for the development of
poststenotic dilatation and coronary artery disease.
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